Tag: Antiparasitic drug

Originally developed as an anticancer agent, miltefosine later emerged as the world's first effective oral drug for leishmaniasis, a neglected tropical disease. This was a significant breakthrough, offering a convenient alternative to traditional parenteral treatments for visceral leishmaniasis (VL). The drug, sold under the brand name Impavido in some regions, has demonstrated high cure rates, though its efficacy can vary by geographic location and parasite species.

In 2015, the Nobel Prize was awarded for discoveries related to avermectin and ivermectin, highlighting the drug's immense global health impact. Understanding how you make ivermectin reveals a complex, multi-stage process far beyond the scope of a home laboratory, involving specialized microbial fermentation and chemical synthesis.